BioCorRx (BICX) EBIT Margin (2011 - 2026)
BioCorRx's (BICX) quarterly EBIT Margin came in at 445.61% in Q1 2026, up 24969.0% year-on-year from N/an in Q1 2025, and down 134.47% quarter-over-quarter from 190.05% in Q4 2025.
BioCorRx (BICX) EBIT Margin (2011 - 2026) Analysis & Trends
BioCorRx has disclosed EBIT Margin across 16 years of filings, most recently posting 445.61% for Q1 2026.
- EBIT Margin for Q1 2026 came in at 445.61%, up 24969.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 422.68% (up 324193.0% YoY), and the FY2025 annual result was 606.04%, up 6622377.0% from the prior year.
- EBIT Margin came in at 445.61% for Q1 2026 at BioCorRx, down from 190.05% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 190.05% in Q4 2025 to a low of 33852.95% in Q2 2024.
- The 5-year median for EBIT Margin is 2611.93% (2023), against an average of 6729.92%.
- Across the five-year window, EBIT Margin tumbled 2903044 bps in 2024 and soared 3305968 bps in 2025, its largest moves.
- BioCorRx's EBIT Margin stood at 1430.79% in 2022, then sank by 204 bps to 4344.24% in 2023, then sank by 679 bps to 33852.95% in 2024, then soared by 99 bps to 190.05% in 2025, then plunged by 134 bps to 445.61% in 2026.
- The last three EBIT Margin figures came in at 445.61% (Q1 2026), 190.05% (Q4 2025), and 461.79% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 9,308.50% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 12.86% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.45% |
| 10 | BioCorRx | - | - | 189,355.00 | -445.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -445.61% |
| Dec 31, 2025 | -190.05% |
| Sep 30, 2025 | -461.79% |
| Jun 30, 2025 | -793.28% |
| Mar 31, 2025 | -695.29% |
| Jun 30, 2024 | -33,852.95% |
| Mar 31, 2024 | -26,759.45% |
| Dec 31, 2023 | -4,344.24% |
| Sep 30, 2023 | -9,481.20% |
| Jun 30, 2023 | -4,822.52% |
| Mar 31, 2023 | -2,611.93% |
| Dec 31, 2022 | -1,430.79% |
| Sep 30, 2022 | -1,089.70% |
| Jun 30, 2022 | -8,488.66% |
| Mar 31, 2022 | -5,481.40% |
| Dec 31, 2021 | -9,790.91% |
| Sep 30, 2021 | -18,539.74% |
| Jun 30, 2021 | -6,129.32% |
| Mar 31, 2021 | -15,598.74% |
| Dec 31, 2020 | -7,952.62% |